In this podcast, George Bakris, MD, from the University of Chicago, talks about the renal outcomes from the Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) trial. More at: www.consultant360.com/cardiology.

In this podcast, George Bakris, MD, from the University of Chicago, talks about the renal outcomes from the Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) trial. More at: www.consultant360.com/cardiology.

In this podcast, George Bakris, MD, from the University of Chicago, talks about the renal outcomes from the&nbsp;Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) trial. More at: www.consultant360.com/cardiology.

George Bakris, MD, on the Renal Outcomes From the CREDENCE Trial

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share George Bakris, MD, on the Renal Outcomes From the CREDENCE Trial

Sign up to save your podcasts

George Bakris, MD, on the Renal Outcomes From the CREDENCE Trial

George Bakris, MD, on the Renal Outcomes From the CREDENCE Trial

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast